Andrew Huberman· PhD
But I don't know that we have the time for clinical trials on all these bioprospected molecules, or even the molecules that you're talking about, which are already FDA approved.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
But I don't know that we have the time for clinical trials on all these bioprospected molecules, or even the molecules that you're talking about, which are already FDA approved.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.